The target price lets investors set an expected value for an asset, helping define buy or sell points.
Choose whether you would like to receive an alert for your Target Price.
The target price lets investors set an expected value for an asset, helping define buy or sell points.
This asset and the price you set will be removed from your target price list and this cannot be undone.
Congratulations! Your Target Price strategy has reached 5 alerts. Now take the next step: upgrade and unlock unlimited alerts to capture every market opportunity.
Unlock unlimited alerts
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| ARGX | Stock | Healthcare | US$ 56.67 B | 5,03% | |
| KYMR | Stock | Healthcare | US$ 10.85 B | 4,63% | |
| KOD | Stock | Healthcare | US$ 6.22 B | 2,94% | |
| UTHR | Stock | Healthcare | US$ 26.10 B | 2,55% | |
| INSM | Stock | Healthcare | US$ 24.13 B | 2,39% | |
| RVMD | Stock | Healthcare | US$ 42.80 B | 2,38% | |
| MRNA | Stock | Healthcare | US$ 91.20 B | 2,36% | |
| VRTX | Stock | Healthcare | US$ 134.44 B | 2,26% | |
| NTRA | Stock | Healthcare | US$ 56.02 B | 2,25% | |
| PCVX | Stock | Healthcare | US$ 9.57 B | 2,04% | |
| BBIO | Stock | Healthcare | US$ 14.42 B | 1,98% | |
Spyre Therapeutics Inc.
|
SYRE | Stock | Healthcare | US$ 9.26 B | 1,97% |
| PRAX | Stock | Healthcare | US$ 7.83 B | 1,90% | |
| DNTH | Stock | Healthcare | US$ 4.80 B | 1,87% | |
| ALKS | Stock | Healthcare | US$ 7.71 B | 1,82% | |
| CYTK | Stock | Healthcare | US$ 8.66 B | 1,82% | |
| MIRM | Stock | Healthcare | US$ 5.65 B | 1,71% | |
| BCTG | Stock | Financial | US$ 218.05 M | 1,70% | |
CG Oncology, Inc. Common stock
|
CGON | Stock | Healthcare | US$ 5.68 B | 1,62% |
| RYTM | Stock | Healthcare | US$ 5.99 B | 1,60% | |
| ARWR | Stock | Healthcare | US$ 8.71 B | 1,56% | |
| SRRK | Stock | Healthcare | US$ 5.61 B | 1,49% | |
| RLAY | Stock | Healthcare | US$ 3.82 B | 1,49% | |
| DYN | Stock | Healthcare | US$ 3.46 B | 1,46% | |
Erasca Inc
|
ERAS | Stock | Healthcare | US$ 5.12 B | 1,44% |
|
Disc Medicine Inc.
|
IRON | Stock | Healthcare | US$ 3.70 B | 1,44% |
| TVTX | Stock | Healthcare | US$ 4.66 B | 1,39% | |
| MDGL | Stock | Healthcare | US$ 9.16 B | 1,32% | |
| ALNY | Stock | Healthcare | US$ 21.42 B | 1,31% | |
| VRDN | Stock | Healthcare | US$ 2.85 B | 1,30% | |
| TWST | Stock | Healthcare | US$ 9.45 B | 1,27% | |
| BEAM | Stock | Healthcare | US$ 2.73 B | 1,19% | |
| NRIX | Stock | Healthcare | US$ 2.82 B | 1,15% | |
| GRAL | Stock | Healthcare | US$ 6.42 B | 1,12% | |
| BIIB | Stock | Healthcare | US$ 37.61 B | 1,12% | |
| DNLI | Stock | Healthcare | US$ 3.35 B | 1,09% | |
| CLDX | Stock | Healthcare | US$ 2.33 B | 1,07% | |
| REPL | Stock | Healthcare | US$ 1.96 B | 1,03% | |
| AMGN | Stock | Healthcare | US$ 249.37 B | 1,01% | |
Roivant Sciences Ltd
|
ROIV | Stock | Healthcare | US$ 26.03 B | 0,99% |
| HALO | Stock | Healthcare | US$ 14.60 B | 0,98% | |
| VERA | Stock | Healthcare | US$ 2.30 B | 0,98% | |
| REGN | Stock | Healthcare | US$ 100.69 B | 0,97% | |
| GILD | Stock | Healthcare | US$ 207.72 B | 0,96% | |
| PTGX | Stock | Healthcare | US$ 9.07 B | 0,96% | |
Cogent Biosciences Inc
|
UMRX | Stock | Healthcare | US$ 73.23 M | 0,95% |
| KRYS | Stock | Healthcare | US$ 9.04 B | 0,95% | |
Palvella Therapeutics, Inc
|
PVLA | Stock | Healthcare | US$ 2.20 B | 0,95% |
| XNCR | Stock | Healthcare | US$ 2.60 B | 0,94% | |
| IMVT | Stock | Healthcare | US$ 6.18 B | 0,89% | |
| VCYT | Stock | Healthcare | US$ 4.22 B | 0,87% | |
Oruka Therapeutics, Inc.
|
ORKA | Stock | Healthcare | US$ 6.59 B | 0,85% |
| IDYA | Stock | Healthcare | US$ 3.12 B | 0,85% | |
| ASND | Stock | Healthcare | US$ 16.46 B | 0,81% | |
| IONS | Stock | Healthcare | US$ 6.72 B | 0,79% | |
| SMMT | Stock | Healthcare | US$ 12.60 B | 0,78% | |
| ABSI | Stock | Healthcare | US$ 1.72 B | 0,77% | |
| STOK | Stock | Healthcare | US$ 1.78 B | 0,73% | |
| INCY | Stock | Healthcare | US$ 23.97 B | 0,73% | |
| XENE | Stock | Healthcare | US$ 3.70 B | 0,64% | |
| CGEM | Stock | Healthcare | US$ 967.96 M | 0,63% | |
|
TYRA
|
TYRA_old | Stock | Healthcare | US$ 903.02 M | 0,62% |
| CELC | Stock | Healthcare | US$ 3.41 B | 0,61% | |
Monte Rosa Therapeutics Inc
|
GLUE | Stock | Healthcare | US$ 888.11 M | 0,59% |
| ORIC | Stock | Healthcare | US$ 994.03 M | 0,55% | |
Mineralys Therapeutics, Inc. Common Stock
|
MLYS | Stock | Healthcare | US$ 1.50 B | 0,45% |
| GH | Stock | Healthcare | US$ 22.62 B | 0,43% | |
| AGIO | Stock | Healthcare | US$ 1.86 B | 0,37% | |
Enliven Therapeutics Inc.
|
ELVN | Stock | Healthcare | US$ 3.46 B | 0,35% |
|
LB Pharmaceuticals Inc Common Stock
|
LBRX | Stock | Healthcare | US$ 1.30 B | 0,34% |
| CMPS | Stock | Healthcare | US$ 1.22 B | 0,32% | |
| TRVI | Stock | Healthcare | US$ 1.97 B | 0,32% | |
| CRVS | Stock | Healthcare | US$ 826.91 M | 0,32% | |
| DFTX | Stock | Healthcare | US$ 4.49 B | 0,31% | |
Arcus Biosciences Inc
|
RCUS | Stock | Healthcare | US$ 2.43 B | 0,30% |
Alto Neuroscience, Inc.
|
ANRO | Stock | Healthcare | US$ 890.80 M | 0,27% |
ABIVAX Société Anonyme
|
AAVXF | Stock | Healthcare | US$ 12.17 B | 0,24% |
|
Avalyn Pharma Inc. Common Stock
|
AVLN | Stock | Healthcare | US$ 1.19 B | 0,24% |
| TXG | Stock | Healthcare | US$ 8.51 B | 0,21% | |
|
Eliem Therapeutics Inc
|
ELYM | Stock | Healthcare | US$ 342.68 M | 0,21% |
Bicara Therapeutics Inc. Common Stock
|
BCAX | Stock | Healthcare | US$ 592.91 M | 0,19% |
Average Investor10 user rating
4.0
(0 people)
T. Rowe Price Biotech ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $10.76 million.
Over the past 12 months, T. Rowe Price Biotech ETF recorded a return of -, with its price trading between $22.72 and $25.51 during the same period.
The ETF is traded under the ticker TDNA.
The current price of TDNA is $24.72. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
TDNA is currently trading at $24.72, with a market capitalization of approximately $10.762.220,00. Over the past year, the ETF has delivered a - return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in TDNA through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol TDNA, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, TDNA has returned 2.79%, and - over the past year.
If you were to purchase 100 shares of TDNA at the current price of $24.72, your total investment would be $2,472.00.
After 1 month the profitability would be $2,540.97.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
